key stock movers

Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Zevra Therapeutics reported quarterly earnings of 19 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $34.125 million which beat the analyst consensus estimate of $28.051 million.

Zevra Therapeutics shares jumped 17.2% to $10.70 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

Losers

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.